Hanna Dietrich, Chiara Knobel, Lea Portmann, Julian Metzler, Anne Muendane, Angela Niggli, Maria S Neumeier, Patrick Imesch, Gabriele S Merki-Feld
Journal: The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception 2023;28(3):198-204
PMID: 37132337
OBJECTIVE
Primary aim of this study was to investigate endometriosis characteristics of patients with psychiatric conditions or depression. The secondary aim was to study tolerability of dienogest in this context.
METHODS
This observational case-control study included endometriosis data from patients visiting our clinic from 2015-2021. We collected information from patient charts and in phone interviews based on a structured survey. Patients with surgical confirmed endometriosis were included.
RESULTS
344 patients fulfilled the inclusion criteria: = 255 no psychiatric disorder, = 119 any psychiatric disorder and = 70 depression. Patients with depression (EM-D, =.018; =.035) or psychiatric condition (EM-P, =.020; =.048) suffered more often from dyspareunia and dyschezia. EM-P patients had more often primary dysmenorrhoea with higher pain scores (=.045). rASRM stage or localisation of lesions did not differ. EM-D and EM-P patients discontinued dienogest treatment more often related to worsening of mood (= .001, =.002).
CONCLUSION
EM-D or EM-P had a higher prevalence of pain symptoms. This could not be attributed to differences in rASRM stage or location of endometriosis lesions. Strong primary dysmenorrhoea might predispose to develop chronic pain-based psychological symptoms. Therefore, early diagnosis and treatment are relevant. Gynaecologist should be aware of the potential impact of dienogest on mood.
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.